<DOC>
	<DOCNO>NCT02700776</DOCNO>
	<brief_summary>The purpose study find protein level blood ( called PC Cell Derived Growth Factor glycoprotein 88 [ GP88 ] ) , combine standard mammography screening , help detect breast cancer well mammography screen alone . Earlier research show certain glycoprotein 88 ( GP88 ) high woman breast cancer . In study , investigator measure level GP88 blood healthy woman mammography screen breast cancer . The investigator plan correlate result mammogram GP-88 level .</brief_summary>
	<brief_title>1380GCC : Prospective Study GP-88 Blood Test Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening Breast Cancer</brief_title>
	<detailed_description>Eligible healthy woman &gt; = 40 year old average risk develop breast cancer offer participation study time present routine screening mammogram ( MM ) University Maryland Breast Screening Center Baltimore Washington Medical Center ; include woman present center referral diagnostic workup recent screen diagnosis breast cancer &lt; = 3 month mammographic finding screen MM BIRADS 0-6 &lt; = 3 month . Informed consent review study participant She ask She wish participate study . Once volunteer agree sign consent , eligibility criterion review study coordinator eligible patient enrol . Her MM , US MRI result obtain study subject assign one 3 cohort patient . COHORT I-BIRADS 1 2 , COHORT II -BIRADS 3 COHORT III-BIRADS 4-6 . The first blood sample ( 20ml ) GP-88 drawn within 31 day initial signing informed consent . It expect majority woman attend screening diagnostic program UM Breast Center approach study . The investigator expect screen 1400 consent approximately 800 woman 12 month . Once deem eligible study participant first GP-88 blood sample drawn ( 20ml ) within 31 day sign consent . The investigator make every effort draw blood sample GP-88 day visit breast center try ask study participant come back blood sample draw unless patient willing . However study participant option GP-88 blood sample drawn within 31 day screen diagnostic MM , US breast MRI biopsy wish participate day visit . If initial-first blood sample never draw patient consider screen failure , subsequent blood sample draw patient return follow screen diagnostic MM test recommended radiologist , replace another subject .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Female great equal 40 year . Presenting UM Breast Center BWMC breast imaging : screening diagnostic mammogram , breast ultrasound ( US ) , breast MRI , stereotactic core needle biopsy , ultrasound core needle biopsy , MRI guide breast biopsy . Patients recent screen diagnosis breast cancer &lt; = 3months . Patients present mammogram finding BIRADS 06 &lt; =3 month . Able understand willingness sign write informed consent document . Patients personal history stage 04 breast cancer &gt; 3months . Patients know severe and/or uncontrolled medical psychiatric condition condition could affect participation study , personal history malignancy . Patients unfit unable comply breast image study mammogram , ultrasound , MRI breast biopsy study proceduresblood draw . Patients personal history ovarian cancer cancer . Patients personal history breast biopsy positive atypical ductal hyperplasia ( ADH ) , atypical lobular hyperplasia ( ALH ) , lobular carcinoma situ ( LCIS ) .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>screen mammogram</keyword>
	<keyword>GP88</keyword>
	<keyword>breast cancer</keyword>
</DOC>